Connecting you to content on EBSCOhost

Works by Aguilar-García, Candelaria

Results: 4

1

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy.

Published in:

Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01845-4

By:

Sordo-Bahamonde, Christian;
Lorenzo-Herrero, Seila;
Granda-Díaz, Rocío;
Martínez-Pérez, Alejandra;
Aguilar-García, Candelaria;
Rodrigo, Juan P.;
García-Pedrero, Juana M.;
Gonzalez, Segundo

Publication type:

Article

2

Correction: Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements.

Published in:

2024

By:

Martínez-Pérez, Alejandra;
Granda-Díaz, Rocío;
Aguilar-García, Candelaria;
Sordo-Bahamonde, Christian;
Gonzalez, Segundo

Publication type:

Correction Notice

3

Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements.

Published in:

Biomarker Research, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40364-024-00671-0

By:

Martínez-Pérez, Alejandra;
Granda-Díaz, Rocío;
Aguilar-García, Candelaria;
Sordo-Bahamonde, Christian;
Gonzalez, Segundo

Publication type:

Article

4

BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2529, doi. 10.1007/s00262-023-03435-1

By:

Sordo-Bahamonde, Christian;
Lorenzo-Herrero, Seila;
Martínez-Pérez, Alejandra;
Gonzalez-Rodriguez, Ana P.;
Payer, Ángel R.;
González-García, Esther;
Aguilar-García, Candelaria;
González-Rodríguez, Sara;
López-Soto, Alejandro;
García-Torre, Alejandra;
Gonzalez, Segundo

Publication type:

Article